维普中文期刊产品整合服务
34篇 您的检索式:作者名="PODOLOFF"
    题名 作者 年代 出处 被引量
1Lymphomatous involvement of gastrointestinal tract: Evaluation by positron emission tomography with ^(18)F-fluorodeoxyglucose显示文摘AIM: To demonstrate the 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) findings in patients with non-Hodgkin's lymphoma (NHL) involving the gastrointestinal (GI) tract and the clinical utility of modality despite of the known normal uptake of FDG in the GI tract.METHODS: Thirty-three patients with biopsy-proven gastrointestinal NHL who had undergone FDG-PET scan were included. All the patients were injected with 10-15 mCi FDG and scanned approximately 60 min later with a CTI/Siemens HR (+) PET scanner. PET scans were reviewed and the maximum standard uptake value (SUVmax) of the lesions was measured before and after the treatment,if data were available and compared with histologic diagnoses.RESULTS: Twenty-five patients had a high-grade lymphoma and eight had a low-grade lymphoma. The stomach was the most common site of the involvement (20 patients). In high-grade lymphoma, PET showed focal nodular or diffuse hypermetabolic activity. The average SUVmax±SD was 11.58±5.83. After the therapy,the patients whose biopsies showed no evidence of lymphoma had a lower uptake without focal lesions.The SUVmax±SD decreased from 11.58±5.83 to 2.21±0.78. In patients whose post-treatment biopsies showed lymphoma, the SUVmax±SD was 9.42±6.27. Low-grade follicular lymphomas of the colon and stomach showed diffuse hypermetabolic activity in the bowel wall (SUVmax 8.2 and 10.3, respectively). The SUVmax was 2.02-3.8 (mean 3.02) in the stomach lesions of patients with MALT lymphoma.CONCLUSION: 18F-FDG PET contributes to the diagnosis of high-grade gastrointestinal non-Hodgkin's lymphoma,even when there is the normal background FDG activity. Furthermore, the SUV plays a role in evaluating treatment response. Low-grade NHL demonstrates FDG uptake but at a lesser intensity than seen in high-grade NHL.Sith Phongkitkarun Vithya Varavithya Toshiki Kazama Silvana C Faria Martha V Mar Donald A Podoloff Homer A Macapinlac 2005World Journal of Gastroenterology2005,11,46:6
2Bone imaging in metastatic breast cancer显示文摘Hamaoka T Madewell JE Podoloff DA 2004J Clin Oncol2004,22,:1
3Computerized occlusal analysis: a new technology 显示文摘Maness Wl Benjamin M Podoloff R 1987Quintessence Int1987,18,4:1
4Computerizedocclusal analysis: a new technology 显示文摘Maness W L Benjamin M PodolofF R 1987Quintessence Int1987,18,4:1
5Imaging of gastrointestinal stromal tumors and assessment of benefit from systemic therapy显示文摘Boonsidkamchai P Podoloff DA Choi H 2009Hematol Oncol Clin North Am2009,23,1:1
6NCCN task force report positron emission tomography(PET)/computed tomography(CT) scanning in cancer显示文摘Podoloff DA Advani RH Allred C 0,,1:1
7Distribution of occlusal contacts in maximum intercuspation 显示文摘Maness WL Podoloff R 1989J Prosthet Dent1989,62,2:1
8Bone imaging in metastatic breast cancer显示文摘Hamaoka T Madewell J E Podoloff D A 2004J Clin Oncol2004,22,14:1
9NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer 显示文摘Podoloff DA Advani RH Allred C 2007J Natl Compr Cane Netw2007,51,:1
10Bone imaging in metastatic breast cancer显示文摘Hamaoka T Madewell JE Podoloff DA 2004J Clin Oncol2004,22,14:1
11NCCN task force: clinical utility of PET in a variety of tumor types显示文摘Podoloff DA Ball DW Ben-Josef E 2009J Natl Compr Canc Netw2009,7,2:1
12Bone imaging in metastatic breast cancer显示文摘Hamaoka T Madewell JE Podoloff DA 2004J Clin Oncol2004,22,14:1
13Bone imaging in metastatic breast cancer显示文摘Hamaoka T Madewell JE Podoloff DA 2004J Clin Oncol2004,22,14:1
14Bone imaging in metastatic breast cancer显示文摘Hamaoka T Madewell JE Podoloff DA 2004J Clin Oncol2004,22,14:1
15Bone imaging in metastatic breast cancer显示文摘Hamaoka T Madewell JE Podoloff DA 2004J Clin Oncol2004,22,14:1
16Effect of colony-stimulating factor and conventional-or high-dose chemotherapy on FDG uptake in bone marrow显示文摘Kazama T Swanston N Podoloff D A 2005Eur J Nucl Med Mol Imaging2005,32,12:1
17Bone Imaging in Metastatic Breast Cancer显示文摘Hamaoka T Madewell JE Podoloff DA 2004J Clin Oncol2004,22,14:1
18Bone imaging in metastatic breast cancer显示文摘HAMAOKA T MADEWELL J E PODOLOFF D A 0,,14:1
19Bone imaging in metastatic breast cancer显示文摘Hamaoka T Madewell JE Podoloff DA 2004J Clin Oncol2004,22,14:1
20Bone imaging in metastatic breast cancer显示文摘Hamaoka T Madewell JE Podoloff DA 2004J Clin Oncol2004,22,14:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费